Novel antiplatelet and antithrombotic activities of essential oil from Lavandula hybrida Reverchon "grosso"

Phytomedicine

Volumn 11, Issue 7-8, 2004, Pages 596-601

  Ballabeni, V ^a   Tognolini, M ^a   Chiavarini, M ^a   Impicciatore, M ^a   Bruni, R ^a   Bianchi, A ^a   Barocelli, E ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Bleeding; Clot retraction; Essential oil; Lamiaceae; Lavandula hybrida; Platelet aggregation; Pulmonary thromboembolism

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; ARACHIDONIC ACID; BETA PINENE; BISABOLOL; CAMPHENE; CAMPHOR; CARYOPHYLLENE OXIDE; CINEOLE; COLLAGEN; ESSENTIAL OIL; HEXYL ACETATE; HEXYL BUTANOATE; HEXYL ISOBUTANOATE; LAVENDER EXTRACT; LAVENDER OIL; LINALOOL; LINALYL ACETATE; MYRCENE; NATURAL PRODUCT; OCIMENE; OCTEN 3 OL ACETATE; PINENE; PLANT EXTRACT; TERPINEN 4 OL; TERPINEOL; THROMBIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BLOOD CLOTTING; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; GUINEA PIG; HEMOSTASIS; IC 50; IN VITRO STUDY; IN VIVO STUDY; LAVANDULA HYBRIDA; LUNG EMBOLISM; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA;

CAVIA PORCELLUS; LAMIACEAE; LAVANDULA; LAVANDULA ANGUSTIFOLIA; LAVANDULA HYBRIDA; SUS SCROFA;

EID: 7044240738     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2004.01.002     Document Type: Article

References (22)

1. Adams, R.P., 2001. Identification of essential oil compounds by GC-quadrupole mass-spectometry. Allured Publishing Corporation: Carol Stream, Illinois, USA.
2. Akhondzadeh, S., Kashani, L., Fotouhi, A., Jarvandi, S., Mobaseri, M., Moin, M., Khani, M., Jamshidi, A.H., Baghalian, K., Taghizadeh, M., 2003. Comparison of Lavandula angustifolia Mill. Tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 27, 123-127.
3. Born, G.V.R., 1962. Aggregation by ADP and its reversal. Nature 194, 927-929.
4. Cavanagh, H.M.A., Wilkinson, J.M., 2002. Biological activities of lavender essential oil. Phytother. Res. 16, 301-308.
5. Coller, B.S., Anderson, K., Weisman, H.F., 1995. New antiplatelet agents: platelet GPIIb/IIIa antagonists. Thromb. Haemostasis 74, 302-308.
6. Collet, J.P., Montalescot, G., Lesty, C., Soria, J., Mishal, Z., Thomas, D., Soria, C., 2001. Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis. Arterioscler. Thromb. Vasc Biol. 21, 142-148.
7. Davidson, I., Henry, J.B., 1974. Clinical Diagnosis of Laboratory Methods. WB Sanders Company, Philadelphia, p. 438.
8. Dejana, E., Callioni, A., Quintana, A., De Gaetano, G., 1979. Bleeding time in laboratory animals. II. A comparison of different assay conditions in rats. Thromb. Res. 15, 191-197.
9. DiMinno, G. (1983). Mouse antithrombotic assays: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol. J. Pharmacol. Exp. Therapeut., 227, 57-60.
10. Fitzgerald, D.J., 2001. Vascular biology of thrombosis. The role of platelet-vessel wall adhesion. Neurology 57, S1-4.
11. Gilani, A.H., Aziz, N., Khan, M.A., Shaheen, F., Jabeen, Q., Siddiqui, B.S., Herzig, J.W., 2000. Ethnopharmacological evaluation of the anticonvulsant, sedative and antispasmodic activities of Lavandula stoechas L. J. Ethnopharmacol. 71, 161-167.
12. Hirose, H., Kimura, T., Okada, M., Itoh, Y., Ishida, F., Mochizuki, N., Nishibe, T., Nishikibe, M., 2000. Antiplatelet and antithrombotic effects of a novel selective phosphodiesterase 3 inhibitor, NSP-513, in mice and rats. Jpn. J. Pharmacol. 82, 188-198.
13. Letizia, C.S., Cocchiara, J., Lalko, J., Api, A.M., 2003a. Fragrance material review on linalool. Food Chem. Toxicol. 41, 943-964.
14. Letizia, C.S., Cocchiara, J., Lalko, J., Api, A.M., 2003b. Fragrance material review on linalyl acetate. Food Chem. Toxicol. 41, 965-976.
15. Lis-Balchin, M., Hart, S., 1999. Studies on the mode of action of the essential oil of lavender (Lavandula angustifolia). Phytother. Res. 13, 540-542.
16. Louis, M., Kowalski, S.D., 2002. Use of aromatherapy with hospice patients to decrease pain, anxiety, and depression and to promote an increased sense of well-being. Am. J. Hospice Palliative Care 19, 381-386.
17. Morris, N., 2003. The effects of lavender (Lavandula angustifolia) baths on psychological well-being: two exploratory randomised control trials. Complement Ther. Med. 10, 223-228.
18. Peana, A.T., D'Aquila, P.S., Chessa, M.L., Moretti, M.D., Serra, G., Pippia, P., 2003. (-)-Linalool produces antinociception in two experimental models of pain. Eur. J. Pharmacol. 460, 37-41.
19. Peana, A.T., D'Aquila, P.S., Panin, F., Serra, G., Pippia, P., Moretti, M.D., 2002. Anti-inflammatory activity of linalool and linalyl acetate constituents of essential oils. Phytomedicine 9, 721-726.
20. Prevost, N., Woulfe, D., Tognolini, M., Brass, L.F., 2003. Contact-dependent signalling during the late events of platelet activation. J. Thromb. Haemostasis 1, 1613-1627.
21. Van De Graaff, E., Steinhubl, S.R., 2001. Complications of oral antiplatelet medications. Current Cardiol. Rep. 3, 371-379.
22. Wong, P.C., Crain, E.J., Watson, C.A., Zaspel, A.M., Wright, M.R., Lam, P.Y., Pinto, D.J., Wexler, R.R., Knabb, R.M., 2002. Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally active pyrazole antithrombotic agent, on arterial thrombosis in rabbits. J. Pharmacol. Exp. Ther. 303, 993-1000.